In a bid to improve competition in the industry, the U.S. Federal Trade Commission is challenging the patents of 20 different ...

GSK’s total sales increased 10% in the first quarter of 2024 compared to the same period last year, thanks in large part to ...

J&J and BMS’ challenges to Medicare drug price negotiations shut down in federal court less than a week after BMS announced it was laying off more than 2,000 employees.

The FDA on Tuesday approved the use of a sprinkle capsule formulation of Neurocrine Biosciences’ Ingrezza (valbenazine) for ...

Pfizer announced its first-quarter 2024 earnings on Wednesday, reporting a 20% year-over-year decline in revenue attributable ...

Based on strong overall and progression-free survival data in its Phase III confirmatory study, Pfizer and Genmab’s ...

Enlaza Therapeutics on Tuesday announced financing led by the Life Sciences Group of J.P. Morgan Asset Management’s Private ...

Thanks to strong sales of its blockbuster drugs Mounjaro and Zepbound, Eli Lilly on Tuesday reported nearly $8.77 billion in ...

Big Pharma took another hit in court Monday as a federal judge in New Jersey threw out challenges by Johnson & Johnson and ...

Under the latest teaming between the two companies, who have worked together since 2010, Novartis will pay $180 million ...

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu significantly improved progression-free survival in ...

The United States has been responsible for many important inventions over the last century and prides itself on being a ...